Please provide your email address to receive an email when new articles are posted on . Having a chronic respiratory infection in addition to bronchiectasis heightened the risk for an exacerbation and ...

Bronchiectasis is a condition where the bronchial tubes of your lungs are permanently damaged, widened, and thickened. These damaged air passages allow bacteria and mucus to build up and pool in your ...

Patients with bronchiectasis recovering from severe COVID-19 face higher risks of exacerbation and mortality compared to nonsevere cases. The study utilized data from Korea's National Health Insurance ...

Bronchiectasis is a lung condition that causes a persistent cough and excess phlegm, or sputum. It is a permanent condition that gets worse over time. It can be fatal. The bronchi dilate, usually ...

The ASPEN randomized trial showed that novel brensocatib cut the annualized rate of pulmonary exacerbations by around 20% compared with placebo. Brensocatib is a DPP-1 inhibitor that works by reducing ...

We found no new evidence that affects the recommendations. For more information, see the surveillance decision. This guideline updates and replaces NICE evidence summaries ESUOM25, ESUOM38 and ES12.